Ventilation–Perfusion Mismatch after Lung Ischemia–Reperfusion
- 1 October 1999
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 160 (4) , 1179-1187
- https://doi.org/10.1164/ajrccm.160.4.9808034
Abstract
Lung ischemia-reperfusion provokes pulmonary hypertension and increased microvascular permeability with subsequent edema formation and hypoxemia. We exposed buffer-perfused rabbit lungs to 120 and 180 min of warm ischemia. After reperfusion, gas exchange disturbances were analyzed by the multiple inert gas elimination technique (MIGET). Additionally, ischemic lungs were treated with different doses of inhaled nitric oxide (NO) throughout reperfusion. Reperfusion provoked a transient pulmonary artery pressure elevation, followed by progressive pulmonary edema formation. After 120 min of ischemia, severe ventilation-perfusion (V A/Q) mismatch developed within 15 min of reperfusion, with the appearance of low V A/Q areas and marked broadening of both perfusion and ventilation distribution in the midrange V A/Q regions. In parallel, shunt flow increased from less than 2% to approximately 17%. Inhalation of NO suppressed the pressor response, edema formation, as well as V A/Q mismatch and shunt flow. Concentrations of 10 and 50 ppm NO were equipotent, surpassing the efficacy of 1 or 250 ppm NO. Inhalation of NO, however, did not protect from the overwhelming gas exchange and fluid balance disturbances provoked by 180 min ischemia. In conclusion, severe abnormalities in gas exchange occurred rapidly upon reperfusion of ischemic lungs. Prophylactic NO inhalation may be considered for maintenance of gas exchange in settings of ischemia-reperfusion including lung transplantation.Keywords
This publication has 30 references indexed in Scilit:
- Low-Dose Nitric Oxide Inhalation During Initial Reperfusion Enhances Rat Lung Graft FunctionThe Annals of Thoracic Surgery, 1997
- Prevention of Reperfusion Injury by Inhaled Nitric Oxide in Lungs Harvested From Non-Heart-Beating DonorsThe Annals of Thoracic Surgery, 1996
- DONOR PRETREATMENT WITH INTRAVENOUS PROSTACYCLIN VERSUS INHALED NITRIC OXIDE IN EXPERIMENTAL LUNG TRANSPLANTATION1Transplantation, 1996
- Inhaled Nitric Oxide Reduces Pulmonary Transvascular Albumin Flux in Patients with Acute Lung InjuryAnesthesiology, 1995
- Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphateThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Pulmonary reimplantation response in single-lung transplantationEuropean Respiratory Journal, 1995
- Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.Journal of Clinical Investigation, 1992
- Reoxygenation of endothelial cells increases permeability by oxidant-dependent mechanisms.Circulation Research, 1992
- Role of reactive oxygen species in reperfusion injury of the rabbit lung.Journal of Clinical Investigation, 1989
- PULMONARY MICROCIRCULATORY HEMODYNAMICSAnnals of the New York Academy of Sciences, 1982